{"id":5463,"date":"2022-03-25T15:47:15","date_gmt":"2022-03-25T05:47:15","guid":{"rendered":"https:\/\/metronorth.health.qld.gov.au\/staff-news\/?p=5463"},"modified":"2022-08-22T08:39:44","modified_gmt":"2022-08-21T22:39:44","slug":"edr-20220325","status":"publish","type":"post","link":"https:\/\/metronorth.health.qld.gov.au\/staff-news\/executive-messages\/2022\/03\/edr-20220325","title":{"rendered":"Message from the Executive Director Research"},"content":{"rendered":"
<\/div>
\n

Message from the Executive<\/strong><\/p>\n

Director Research<\/strong><\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/div>\n
\"Executive

Executive Director Research: Professor Dan Chambers<\/p><\/div>\n

I am delighted to announce that once again, Metro North will be partnering with The University of Queensland, Queensland University of Technology, Queensland Institute of Medical Research Berghofer and Griffith University to offer a fourth round of the Collaborative Research Grants Program in 2022. I am also very pleased to welcome the University of the Sunshine Coast as a Collaborating Organisation to this scheme.<\/h4>\n

The Collaborative Research Grants will enable new collaborative research between clinicians, academics, and scientists with the potential to lead to ongoing research of direct benefit to Metro North Health patients and the community. The key objectives of the Collaborative Research Grants are to:<\/p>\n